Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
14,731
archived clinical trials in
Psychiatric

Comparison of Couple-Based PTSD Treatment and Couple-Based PTSD Education
Couples Treatment of PTSD in OEF/OIF Veterans
Status: Enrolling
Updated:  3/11/2016
Southeast Louisiana Veterans Health Care System, New Orleans, LA
mi
from
New Orleans, LA
Comparison of Couple-Based PTSD Treatment and Couple-Based PTSD Education
Couples Treatment of PTSD in OEF/OIF Veterans
Status: Enrolling
Updated: 3/11/2016
Southeast Louisiana Veterans Health Care System, New Orleans, LA
mi
from
New Orleans, LA
Click here to add this to my saved trials
D-Cycloserine Facilitation of Cocaine - Cue Extinction
D-Cycloserine Facilitation of Cocaine - Cue Extinction
Status: Enrolling
Updated:  3/14/2016
Medical University of South Carolina
mi
from
Charleston, SC
D-Cycloserine Facilitation of Cocaine - Cue Extinction
D-Cycloserine Facilitation of Cocaine - Cue Extinction
Status: Enrolling
Updated: 3/14/2016
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
D-Cycloserine Facilitation of Cocaine - Cue Extinction
D-Cycloserine Facilitation of Cocaine - Cue Extinction
Status: Enrolling
Updated:  3/14/2016
Behavioral Health Services of Pickens County
mi
from
Pickens, SC
D-Cycloserine Facilitation of Cocaine - Cue Extinction
D-Cycloserine Facilitation of Cocaine - Cue Extinction
Status: Enrolling
Updated: 3/14/2016
Behavioral Health Services of Pickens County
mi
from
Pickens, SC
Click here to add this to my saved trials
Sensoril(Ashwaganhda)for Bipolar Disorder
Sensoril® (Ashwagandha) - A Standardized Extract From a Medicinal Plant - (Withania Somnifera) for Cognitive Enhancement in Persons With Bipolar Disorder: A Parallel Group, Randomized Double Blind, and Placebo Controlled Study
Status: Enrolling
Updated:  3/14/2016
Western Psychiatric Institute and Clinic/ University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Sensoril(Ashwaganhda)for Bipolar Disorder
Sensoril® (Ashwagandha) - A Standardized Extract From a Medicinal Plant - (Withania Somnifera) for Cognitive Enhancement in Persons With Bipolar Disorder: A Parallel Group, Randomized Double Blind, and Placebo Controlled Study
Status: Enrolling
Updated: 3/14/2016
Western Psychiatric Institute and Clinic/ University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Sensoril(Ashwaganhda)for Bipolar Disorder
Sensoril® (Ashwagandha) - A Standardized Extract From a Medicinal Plant - (Withania Somnifera) for Cognitive Enhancement in Persons With Bipolar Disorder: A Parallel Group, Randomized Double Blind, and Placebo Controlled Study
Status: Enrolling
Updated:  3/14/2016
Western Psychiatric Institute and Clinic
mi
from
Pittsburgh, PA
Sensoril(Ashwaganhda)for Bipolar Disorder
Sensoril® (Ashwagandha) - A Standardized Extract From a Medicinal Plant - (Withania Somnifera) for Cognitive Enhancement in Persons With Bipolar Disorder: A Parallel Group, Randomized Double Blind, and Placebo Controlled Study
Status: Enrolling
Updated: 3/14/2016
Western Psychiatric Institute and Clinic
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated Hypertriglyceridemia
Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated Hypertriglyceridemia
Status: Enrolling
Updated:  3/14/2016
Massachusetts General Hospital
mi
from
Boston, MA
Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated Hypertriglyceridemia
Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated Hypertriglyceridemia
Status: Enrolling
Updated: 3/14/2016
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Integrated Treatment of OEF/OIF Veterans With PTSD & Substance Use Disorders
Integrated Treatment of Operation Enduring Freedom/Operation Iraqi Freedom Veterans With Post-traumatic Stress Disorder and Substance Use Disorders
Status: Enrolling
Updated:  3/14/2016
Medical University of South Carolina
mi
from
Charleston, SC
Integrated Treatment of OEF/OIF Veterans With PTSD & Substance Use Disorders
Integrated Treatment of Operation Enduring Freedom/Operation Iraqi Freedom Veterans With Post-traumatic Stress Disorder and Substance Use Disorders
Status: Enrolling
Updated: 3/14/2016
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
A Double-Blind Comparison of Naltrexone and Placebo in Adults With Attention Deficit Hyperactivity Disorder
A Double-Blind Comparison of Naltrexone and Placebo in Adults With Attention Deficit Hyperactivity Disorder
Status: Enrolling
Updated:  3/14/2016
Massachusetts General Hospital
mi
from
Cambridge, MA
A Double-Blind Comparison of Naltrexone and Placebo in Adults With Attention Deficit Hyperactivity Disorder
A Double-Blind Comparison of Naltrexone and Placebo in Adults With Attention Deficit Hyperactivity Disorder
Status: Enrolling
Updated: 3/14/2016
Massachusetts General Hospital
mi
from
Cambridge, MA
Click here to add this to my saved trials
A Smoking Intervention Study Using Scheduled Gradual Reduction With Varenicline to Help With Cessation
A Combination of Scheduled Reduced Smoking With Varenicline to Enhance Cessation
Status: Enrolling
Updated:  3/14/2016
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
A Smoking Intervention Study Using Scheduled Gradual Reduction With Varenicline to Help With Cessation
A Combination of Scheduled Reduced Smoking With Varenicline to Enhance Cessation
Status: Enrolling
Updated: 3/14/2016
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
An Open-Label Study of Naltrexone in Adults With Attention Deficit Hyperactivity Disorder.
An Open-Label Study of Naltrexone in Adults With Attention Deficit Hyperactivity Disorder.
Status: Enrolling
Updated:  3/14/2016
Massachusetts General Hospital
mi
from
Boston, MA
An Open-Label Study of Naltrexone in Adults With Attention Deficit Hyperactivity Disorder.
An Open-Label Study of Naltrexone in Adults With Attention Deficit Hyperactivity Disorder.
Status: Enrolling
Updated: 3/14/2016
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO)
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes Study
Status: Enrolling
Updated:  3/14/2016
Arkansas Children's Hospital Research Institute
mi
from
Little Rock, AR
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO)
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes Study
Status: Enrolling
Updated: 3/14/2016
Arkansas Children's Hospital Research Institute
mi
from
Little Rock, AR
Click here to add this to my saved trials
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO)
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes Study
Status: Enrolling
Updated:  3/14/2016
Kaiser Permanente Santa Clara
mi
from
Santa Clara, CA
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO)
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes Study
Status: Enrolling
Updated: 3/14/2016
Kaiser Permanente Santa Clara
mi
from
Santa Clara, CA
Click here to add this to my saved trials
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO)
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes Study
Status: Enrolling
Updated:  3/14/2016
Children's National Medical Center
mi
from
Washington DC,
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO)
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes Study
Status: Enrolling
Updated: 3/14/2016
Children's National Medical Center
mi
from
Washington DC,
Click here to add this to my saved trials
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO)
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes Study
Status: Enrolling
Updated:  3/14/2016
Washington University
mi
from
St. Louis, MO
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO)
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes Study
Status: Enrolling
Updated: 3/14/2016
Washington University
mi
from
St. Louis, MO
Click here to add this to my saved trials
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO)
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes Study
Status: Enrolling
Updated:  3/14/2016
Seattle Children's Hospital
mi
from
Seattle, WA
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO)
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes Study
Status: Enrolling
Updated: 3/14/2016
Seattle Children's Hospital
mi
from
Seattle, WA
Click here to add this to my saved trials
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO)
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes Study
Status: Enrolling
Updated:  3/14/2016
Stanford University
mi
from
Palo Alto, CA
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO)
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes Study
Status: Enrolling
Updated: 3/14/2016
Stanford University
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO)
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes Study
Status: Enrolling
Updated:  3/14/2016
UCSF
mi
from
San Francisco, CA
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO)
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes Study
Status: Enrolling
Updated: 3/14/2016
UCSF
mi
from
San Francisco, CA
Click here to add this to my saved trials
Fostering Resilience in Physician Moms
Fostering Resilience: An Intervention for Women Physicians at Risk for Burnout
Status: Enrolling
Updated:  3/14/2016
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Fostering Resilience in Physician Moms
Fostering Resilience: An Intervention for Women Physicians at Risk for Burnout
Status: Enrolling
Updated: 3/14/2016
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Mindfulness Based Resilience Training
Mindfulness Based Resilience Training for Employees at Mayo Clinic
Status: Enrolling
Updated:  3/14/2016
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Mindfulness Based Resilience Training
Mindfulness Based Resilience Training for Employees at Mayo Clinic
Status: Enrolling
Updated: 3/14/2016
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Vigabatrin for Treatment of Cocaine Dependence
Vigabatrin for Treatment of Cocaine Dependence: A Phase II Study
Status: Enrolling
Updated:  3/14/2016
Addiction Treatment Clinic
mi
from
Little Rock, AR
Vigabatrin for Treatment of Cocaine Dependence
Vigabatrin for Treatment of Cocaine Dependence: A Phase II Study
Status: Enrolling
Updated: 3/14/2016
Addiction Treatment Clinic
mi
from
Little Rock, AR
Click here to add this to my saved trials
Vigabatrin for Treatment of Cocaine Dependence
Vigabatrin for Treatment of Cocaine Dependence: A Phase II Study
Status: Enrolling
Updated:  3/14/2016
St. Luke's Hospital Addiction Pharmacology Research Laboratory
mi
from
San Francisco, CA
Vigabatrin for Treatment of Cocaine Dependence
Vigabatrin for Treatment of Cocaine Dependence: A Phase II Study
Status: Enrolling
Updated: 3/14/2016
St. Luke's Hospital Addiction Pharmacology Research Laboratory
mi
from
San Francisco, CA
Click here to add this to my saved trials
Vigabatrin for Treatment of Cocaine Dependence
Vigabatrin for Treatment of Cocaine Dependence: A Phase II Study
Status: Enrolling
Updated:  3/14/2016
Friends Research Institute
mi
from
Torrance, CA
Vigabatrin for Treatment of Cocaine Dependence
Vigabatrin for Treatment of Cocaine Dependence: A Phase II Study
Status: Enrolling
Updated: 3/14/2016
Friends Research Institute
mi
from
Torrance, CA
Click here to add this to my saved trials
Vigabatrin for Treatment of Cocaine Dependence
Vigabatrin for Treatment of Cocaine Dependence: A Phase II Study
Status: Enrolling
Updated:  3/14/2016
Operation PAR
mi
from
Largo, FL
Vigabatrin for Treatment of Cocaine Dependence
Vigabatrin for Treatment of Cocaine Dependence: A Phase II Study
Status: Enrolling
Updated: 3/14/2016
Operation PAR
mi
from
Largo, FL
Click here to add this to my saved trials
Vigabatrin for Treatment of Cocaine Dependence
Vigabatrin for Treatment of Cocaine Dependence: A Phase II Study
Status: Enrolling
Updated:  3/14/2016
The Segal Institute of Clinical Research
mi
from
North Miami, FL
Vigabatrin for Treatment of Cocaine Dependence
Vigabatrin for Treatment of Cocaine Dependence: A Phase II Study
Status: Enrolling
Updated: 3/14/2016
The Segal Institute of Clinical Research
mi
from
North Miami, FL
Click here to add this to my saved trials
Vigabatrin for Treatment of Cocaine Dependence
Vigabatrin for Treatment of Cocaine Dependence: A Phase II Study
Status: Enrolling
Updated:  3/14/2016
Johns Hopkins Bayview Medical Center Center for Chemical Dependence
mi
from
Baltimore, MD
Vigabatrin for Treatment of Cocaine Dependence
Vigabatrin for Treatment of Cocaine Dependence: A Phase II Study
Status: Enrolling
Updated: 3/14/2016
Johns Hopkins Bayview Medical Center Center for Chemical Dependence
mi
from
Baltimore, MD
Click here to add this to my saved trials
Vigabatrin for Treatment of Cocaine Dependence
Vigabatrin for Treatment of Cocaine Dependence: A Phase II Study
Status: Enrolling
Updated:  3/14/2016
Boston University School of Medicine
mi
from
Boston, MA
Vigabatrin for Treatment of Cocaine Dependence
Vigabatrin for Treatment of Cocaine Dependence: A Phase II Study
Status: Enrolling
Updated: 3/14/2016
Boston University School of Medicine
mi
from
Boston, MA
Click here to add this to my saved trials
Vigabatrin for Treatment of Cocaine Dependence
Vigabatrin for Treatment of Cocaine Dependence: A Phase II Study
Status: Enrolling
Updated:  3/14/2016
New York University Mental Health and Addictive Disorders Research Program
mi
from
New York, NY
Vigabatrin for Treatment of Cocaine Dependence
Vigabatrin for Treatment of Cocaine Dependence: A Phase II Study
Status: Enrolling
Updated: 3/14/2016
New York University Mental Health and Addictive Disorders Research Program
mi
from
New York, NY
Click here to add this to my saved trials
Vigabatrin for Treatment of Cocaine Dependence
Vigabatrin for Treatment of Cocaine Dependence: A Phase II Study
Status: Enrolling
Updated:  3/14/2016
Cincinnati Addiction Research Center (CinARC)
mi
from
Cincinnati, OH
Vigabatrin for Treatment of Cocaine Dependence
Vigabatrin for Treatment of Cocaine Dependence: A Phase II Study
Status: Enrolling
Updated: 3/14/2016
Cincinnati Addiction Research Center (CinARC)
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Vigabatrin for Treatment of Cocaine Dependence
Vigabatrin for Treatment of Cocaine Dependence: A Phase II Study
Status: Enrolling
Updated:  3/14/2016
Dayton Veterans Affairs Medical Center
mi
from
Dayton, OH
Vigabatrin for Treatment of Cocaine Dependence
Vigabatrin for Treatment of Cocaine Dependence: A Phase II Study
Status: Enrolling
Updated: 3/14/2016
Dayton Veterans Affairs Medical Center
mi
from
Dayton, OH
Click here to add this to my saved trials
Vigabatrin for Treatment of Cocaine Dependence
Vigabatrin for Treatment of Cocaine Dependence: A Phase II Study
Status: Enrolling
Updated:  3/14/2016
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Vigabatrin for Treatment of Cocaine Dependence
Vigabatrin for Treatment of Cocaine Dependence: A Phase II Study
Status: Enrolling
Updated: 3/14/2016
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Prevention of Post Sexual Assault Stress
Prevention of Postrape Drug Abuse: Replication Study
Status: Enrolling
Updated:  3/14/2016
Hennepin County Medical Center
mi
from
Minneapolis, MN
Prevention of Post Sexual Assault Stress
Prevention of Postrape Drug Abuse: Replication Study
Status: Enrolling
Updated: 3/14/2016
Hennepin County Medical Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Prevention of Post Sexual Assault Stress
Prevention of Postrape Drug Abuse: Replication Study
Status: Enrolling
Updated:  3/14/2016
North Memorial Medical Center
mi
from
Minneapolis, MN
Prevention of Post Sexual Assault Stress
Prevention of Postrape Drug Abuse: Replication Study
Status: Enrolling
Updated: 3/14/2016
North Memorial Medical Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Clinical Trial for Post Traumatic Stress Disorder
Mifepristone After Trauma to Enhance Resilience
Status: Enrolling
Updated:  3/15/2016
Mount Sinai School of Medicine
mi
from
New York, NY
A Clinical Trial for Post Traumatic Stress Disorder
Mifepristone After Trauma to Enhance Resilience
Status: Enrolling
Updated: 3/15/2016
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Omega-3 Fatty Acids and Post Traumatic Stress Disorder (PTSD)
Omega-3 Fatty Acids and PTSD
Status: Enrolling
Updated:  3/15/2016
Durham VA Medical Center
mi
from
Durham, NC
Omega-3 Fatty Acids and Post Traumatic Stress Disorder (PTSD)
Omega-3 Fatty Acids and PTSD
Status: Enrolling
Updated: 3/15/2016
Durham VA Medical Center
mi
from
Durham, NC
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Woodland International Research Inc
mi
from
Little Rock, AR
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Woodland International Research Inc
mi
from
Little Rock, AR
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
South Coast Clinical Trials Inc.
mi
from
Anaheim, CA
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
South Coast Clinical Trials Inc.
mi
from
Anaheim, CA
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Catalina Research Institute
mi
from
Chino, CA
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Catalina Research Institute
mi
from
Chino, CA
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Clinical Innovations Inc.
mi
from
Riverside, CA
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Clinical Innovations Inc.
mi
from
Riverside, CA
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Synergy Escondido
mi
from
Escondido, CA
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Synergy Escondido
mi
from
Escondido, CA
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Florida Clinical Research Center LLC
mi
from
Maitland, CA
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Florida Clinical Research Center LLC
mi
from
Maitland, CA
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Excell Research, Inc.
mi
from
Oceanside, CA
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Excell Research, Inc.
mi
from
Oceanside, CA
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
CNRI - Los Angeles LLC
mi
from
Pico Rivera, CA
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
CNRI - Los Angeles LLC
mi
from
Pico Rivera, CA
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Sharp Mesa Vista Hospital
mi
from
San Diego, CA
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Sharp Mesa Vista Hospital
mi
from
San Diego, CA
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Artemis Institute for Clinical Research
mi
from
San Diego, CA
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Artemis Institute for Clinical Research
mi
from
San Diego, CA
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
California Neuropsychopharmacology Clinical Research Instit
mi
from
San Diego, CA
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
California Neuropsychopharmacology Clinical Research Instit
mi
from
San Diego, CA
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Stanford University School of Medicine
mi
from
Stanford, CA
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Collaborative Neuroscience Network, INC
mi
from
Torrance, CA
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Collaborative Neuroscience Network, INC
mi
from
Torrance, CA
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
MCB Clinical Research Centers-Colorado Springs
mi
from
Colorado Springs, CO
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
MCB Clinical Research Centers-Colorado Springs
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Accurate Clinical Trials
mi
from
Kissimmee, FL
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Accurate Clinical Trials
mi
from
Kissimmee, FL
Click here to add this to my saved trials